Skip to main content

Table 1 Response rate by age groups and prevalence of hr-HPV mRNA stratified by age groups

From: Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection

Age groupHr-HPV positive samplesHr-HPV negative samplesTotal HPV-tested samplesHPV prevalence
 n%n%n%%
≤3911.3111.5121.58.3
40–491215.27310.28510.714.1
50–591620.317023.718623.48.6
60–694050.637552.341552.19.6
70 and 711012.78812.39812.310.2
Total791007171007961009.9
  1. Hr-HPV High risk Human Papillomavirus